Pharma & Healthcare in Argentina: Turning a Corner?
Has Argentina, for years one of the economic basket cases of Latin America, finally turned a corner? And is its pharma industry set for a bounce back? Firebrand TV…
Savant is aware that health is people’s most valuable asset, and seeks to provide patients with drugs that allow them to enjoy a better quality of life.
At only 20 years of age, it has become a company of international renown that works every day to offer more health and a better life to millions of people, from Argentina to the rest of the world. This achievement has been possible due to the excellence and determination of their staff, made up of more than 350 workers from different areas. Having a production based on international quality standards, extraordinary technological skills, a manufacturing facility equipped with leading-edge technology and strategically located corporate headquarters, they strive to attain a maximum-efficiency industrial and business process.
SAVANT has a model manufacturing plant, located in a 110,000-m² area in the town of El Tío, Córdoba, Argentina, where proprietary drugs in various pharmaceutical forms are produced: solid (tablets, film-coated tablets, and capsules), semi-solid (soft capsules and granules), and liquid (syrups, suspensions). The company also has a dedicated facility for producing antibiotics in solid dosage forms, such as film-coated tablets and extemporaneous compounding with beta-lactam active ingredients and clavulanic acid combinations, and a soft capsule facility with a capacity of 150,000 units per hour, being among the most important plants of these characteristics in the country.
Address
Esteban Echeverria 1050
Vicente Lopez
Buenos Aires B1602ABC
Argentina
(+54) 11 4730 4606
Has Argentina, for years one of the economic basket cases of Latin America, finally turned a corner? And is its pharma industry set for a bounce back? Firebrand TV…
Gustavo Pelizzari leads Elea, Argentina’s largest pharmaceutical company by sales volume, employing 1,350 people. Under his leadership, Elea has achieved the unique distinction of simultaneously leading both the retail pharmaceutical…
Gala Díaz Langou, a senior analyst and executive director at Argentina’s premier think tank CIPPEC, assesses the country’s recent transformative journey under President Milei. Drawing on 25 years of institutional…
Keila Barral, founder of Cromodata, brings together a personal journey of resilience and a career in technology to address one of Latin America’s biggest healthcare challenges: fragmented patient data. After…
Argentina’s pharmaceutical industry combines a robust domestic manufacturing base with growing international reach and regulatory credibility. In this interview, Mauricio Claverí, Chief Economist at CILFA, explores how local companies are…
Juan Jose Marconi, Executive Director of Cooperala, offers a unique perspective shaped by decades of leadership across Argentina’s pharmaceutical and healthcare sectors. With a strong academic background in applied mathematics,…
MSD’s Leonardo Semprun, writing in the June 2025 edition of DIA’s Global Forum magazine, reflects on some of the key lessons from the Latin America Town Hall at DIA Europe…
A roundup of some of the biggest stories coming out of Latin American pharma and healthcare, including Mexico’s move to speed up the drug review process; Sanfer’s acquisition of Columbia’s…
A roundup of top stories from Latin American pharma and healthcare, including the beginning of the Mexican government’s consolidated procurement of medicines; Libbs’ new biologics plant; Novo Nordisk’s USD 142.4…
An overview of some of the biggest news from Latin American pharma, including Onconic Therapeutics’ licensing deal with Laboratorios Sanfer for 19 LatAm countries; Lupin’s orphan drug partnership with Argentina’s…
A roundup of some of the latest stories coming out of Latin American pharma and healthcare, including Merck’s new distribution centre in Brazil; the region’s record dengue surge; Roemmers Laboratory’s…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
See our Cookie Privacy Policy Here
